Gain Therapeutics, Inc. (GANX) Tops Q2 EPS by 3c

Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold